Stryker Corp. raises 2024 profit forecast to $11.85-$12.05/share due to strong medical device demand, with Q1 revenue up 9.7% to $5.
Stryker Corp. raised its full-year profit forecast for 2024 to between $11.85 and $12.05 per share due to strong demand for its medical devices and implants. The company reported a 9.7% increase in Q1 revenue to $5.24 billion, surpassing analysts' estimates of $5.10 billion. Stryker now expects organic net sales growth for 2024 to be between 8.5% and 9.5%, an upgrade from its earlier forecast of 7.5% to 9%.
April 30, 2024
10 Articles